Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Cancer Biology & Therapy

The role of ASF1B in disease pathogenesis and treatment: from histone chaperone to clinical target

6 affiliations
  1. 1Department of Urology, West China Hospital Sichuan University Jintang Hospital·Jintang First People's Hospital, Chengdu, China
  2. 2Department of Radiology, West China Hospital Sichuan University Jintang Hospital·Jintang First People's Hospital, Chengdu, China
  3. 3Department of Emergency, West China Hospital Sichuan University Jintang Hospital·Jintang First People's Hospital, Chengdu, China
  4. 4Department of Nursing, West China Hospital Sichuan University Jintang Hospital·Jintang First People's Hospital, Chengdu, China
  5. 5Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China
  6. 6West China Hospital Sichuan University Jintang Hospital·Jintang First People's Hospital, Chengdu, China

Abstract

ASF1B is a critical molecular chaperone for histones H3 and H4 and functions as a core regulator of chromatin assembly, DNA replication, and repair. In recent years, multiple studies have revealed that ASF1B is abnormally overexpressed in various malignant tumors and is correlated with disease progression and poor prognosis, demonstrating its potential as a prognostic biomarker across different cancer types. ASF1B drives tumor cell proliferation, metastasis, treatment resistance, and immune evasion through multiple mechanisms, including direct regulation of the cell cycle, participation in DNA damage repair, and remodeling of the tumor immune microenvironment. Besides, its potential role in non-cancerous diseases has also begun to attract attention. This article systematically reviews the biological characteristics of ASF1B, its expression patterns and functional mechanisms in disease, and explores its translational clinical prospects as a diagnostic marker and therapeutic target, aiming to provide new insights for the precision treatment of related diseases.

Related

  1. The transcription factor PRO44 and the histone chaperone ASF1 regulate distinct aspects of multicellular development in the filamentous fungus Sordaria macrospora.
    Schumacher Di, Lütkenhaus R, Altegoer F +3
    BMC GeneticsPeer-reviewedCC BYFull text19 citedMolecular biology & gene regulationHAL
  2. The dual role of small EVs in asthma and chronic obstructive pulmonary disease: from pathogenesis to clinical translation
    Jun Li, Zhouqiang Li, Haining Hu +3
    Frontiers in MedicinePeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  3. Differential chromatin enrichment of histone H3K27me3 underlies variable cell responses to estrogen and endocrine treatment
    Fleur Chapus, Christopher R. Day, Laura G. Kammel +7
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  4. From Dysbiosis to Disease: How Vaginal Microbiota Shape Group B Streptococcus Pathogenesis
    Julie A. Talbert, Steven D. Townsend
    Chembiochem : a European journal of chemical biologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  5. The role of mitochondrial DNA and RNA in promoting liver disease pathogenesis
    Sanjeevani Raj, Anjali Warhade, Nikkee Kumari +2
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
BibTeX
@article{deng2026role,
  title = {{The role of ASF1B in disease pathogenesis and treatment: from histone chaperone to clinical target}},
  author = {Ying Deng and Hao Xie and Yao Chen and Rong Zhang and Qingrong Yue and Yongkang Wu},
  journal = {Cancer Biology \& Therapy},
  year = {2026},
  month = nov,
  doi = {10.1080/15384047.2026.2755094},
  url = {https://doi.org/10.1080/15384047.2026.2755094},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The role of ASF1B in disease pathogenesis and treatment: from histone chaperone to clinical target
AU  - Ying Deng
AU  - Hao Xie
AU  - Yao Chen
AU  - Rong Zhang
AU  - Qingrong Yue
AU  - Yongkang Wu
PY  - 2026
DA  - 2026/11/03
JO  - Cancer Biology & Therapy
DO  - 10.1080/15384047.2026.2755094
UR  - https://doi.org/10.1080/15384047.2026.2755094
AB  - ASF1B is a critical molecular chaperone for histones H3 and H4 and functions as a core regulator of chromatin assembly, DNA replication, and repair. In recent years, multiple studies have revealed that ASF1B is abnormally overexpressed in various malignant tumors and is correlated with disease progression and poor prognosis, demonstrating its potential as a prognostic biomarker across different cancer types. ASF1B drives tumor cell proliferation, metastasis, treatment resistance, and immune evasion through multiple mechanisms, including direct regulation of the cell cycle, participation in DNA damage repair, and remodeling of the tumor immune microenvironment. Besides, its potential role in non-cancerous diseases has also begun to attract attention. This article systematically reviews the biological characteristics of ASF1B, its expression patterns and functional mechanisms in disease, and explores its translational clinical prospects as a diagnostic marker and therapeutic target, aiming to provide new insights for the precision treatment of related diseases.
SN  - 1538-4047
SN  - 1555-8576
ER  -